Prognostic values of preoperative serum CA199 and NSE on esophageal squamous cell carcinoma patients

Z XIANG, Z LIN, S LIU, H YANG… - Chinese Journal of …, 2019 - pesquisa.bvsalud.org
Objective To explore the effects of preoperative serum cancer antigen 19-9 (CA19-9) and
neuron-specific enolase (NSE) on the prognosis of patients with esophageal squamous cell …

The prognostic values of CA125, CA19. 9, NSE, AND SCC for stage I NSCLC are limited

S Ma, L Shen, N Qian, K Chen - Cancer Biomarkers, 2012 - content.iospress.com
Objective: Amongst the current detections of tumor markers, measurement of serum tumor
markers is the most convenient and the safest way. However, there are few promising serum …

[HTML][HTML] The correlation between common postoperative complications and quality of life, serum tumor markers, and prognosis in patients with esophageal cancer

L Sun, F Xu, X Xu, C Liu - Translational Cancer Research, 2022 - ncbi.nlm.nih.gov
Background Esophageal cancer (EC) is highly malignant, with poor prognosis. The main
forms of treatment are surgery, radiotherapy, and chemotherapy. In recent years, the …

Study of serum CEA and Ca 19.9 in esophageal squamous carcinoma and ROC curve analysis

S Das, L mudra Kakoti, S Ahmed, A Sarma - Asian Pacific Journal of …, 2020 - waocp.com
Background: There are very few studies on the comparative diagnostic value of CEA and
Ca19. 9 in esophageal squamous cell carcinoma (ESCC). Aims and objectives: The aim of …

A retrospective analysis of serum tumor markers found in non-small cell lung cancer

Q Hu, P Xiao, J Li, P Yu - Journal of cancer research and …, 2016 - journals.lww.com
Aim: This paper discusses the retrospective analysis conducted to determine the
significance of diagnostic biomarkers, carcinoembryonic antigens (CEA), cytokeratin …

CYFRA21-1 can predict the sensitivity to chemoradiotherapy of non-small-cell lung carcinoma

J Wang, Y Yi, B Li, Z Wang, H Sun, P Zhang… - Biomarkers, 2010 - Taylor & Francis
Background: The increasing panel of systemic therapies enables the individual
management of lung cancer patients, even in advanced stages. However, predictive tools …

Anti-CDC25B autoantibody predicts poor prognosis in patients with advanced esophageal squamous cell carcinoma

J Dong, B Zeng, L Xu, J Wang, MZ Li, M Zeng… - Journal of translational …, 2010 - Springer
Abstract Background The oncogene CDC25B phosphatase plays an important role in
cancer cell growth. We have recently reported that patients with esophageal squamous cell …

Correlation between changes in serum level of CEA and CYFRA 21-1 and objective response of chemotherapy

MU Xinlin, GAO Zhancheng… - Zhongguo Fei Ai Za …, 2009 - search.proquest.com
背景与目的 血清肿瘤标志物浓度反映肿瘤的代谢或凋亡情况, 化疗后肿瘤标志物的变化有可能
反映化疗的客观疗效. 研究目的在于评价化疗期间血清癌胚抗原 (CEA), 细胞角蛋白 19 片段 …

Diagnostic and prognostic value of Cyfra 21-1 compared with other tumour markers in patients with non-small cell lung cancer: a prospective study of 116 patients

JM Brechot, S Chevret, J Nataf, C Le Gall… - European Journal of …, 1997 - Elsevier
The diagnostic value of Cyfra 21-1 in non-small lung cancer (NSCLC) has been established,
but few studies have focused on its prognostic value. The aim of this study was to compare …

Diagnostic value of serum tumor markers CEA, CYFRA21-1, SCCAg, NSE and ProGRP for lung cancers of different pathological types

J Gao, L Zhang, K Peng, H Sun - Nan Fang yi ke da xue xue bao …, 2022 - europepmc.org
Objective To evaluate the diagnostic value of the serum tumor markers carcinoembryonic
antigen (CEA), cytokeratin-19-fragment (CYFRA21-1), squamous cell carcinoma associated …